Responses
Clinical and epidemiological research
Concise report
Successful reduction of overexposure in patients with rheumatoid arthritis with high serum adalimumab concentrations: an open-label, non-inferiority, randomised clinical trial
Compose a Response to This Article
Other responses
No responses have been published for this article.